These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 8077896

  • 1. An interaction between Gemfibrozil and alpha 1-antitrypsin.
    Janciauskiene S, Eriksson S.
    J Intern Med; 1994 Sep; 236(3):357-60. PubMed ID: 8077896
    [Abstract] [Full Text] [Related]

  • 2. [Gemfibrozil in the treatment of lipid metabolism disorders].
    Vartanova OA, Aleksandrovskaia TN, Shaldaeva VV.
    Klin Med (Mosk); 1994 Sep; 72(1):37-41. PubMed ID: 8196321
    [Abstract] [Full Text] [Related]

  • 3. Gemfibrozil. A reappraisal of its pharmacological properties and place in the management of dyslipidaemia.
    Spencer CM, Barradell LB.
    Drugs; 1996 Jun; 51(6):982-1018. PubMed ID: 8736620
    [Abstract] [Full Text] [Related]

  • 4. Effect of gemfibrozil on composition of lipoproteins and distribution of LDL subspecies.
    Tsai MY, Yuan J, Hunninghake DB.
    Atherosclerosis; 1992 Jul; 95(1):35-42. PubMed ID: 1642690
    [Abstract] [Full Text] [Related]

  • 5. Gemfibrozil reduces plasma C-reactive protein levels in abdominally obese men with the atherogenic dyslipidemia of the metabolic syndrome.
    Després JP, Lemieux I, Pascot A, Alméras N, Dumont M, Nadeau A, Bergeron J, Prud'homme D.
    Arterioscler Thromb Vasc Biol; 2003 Apr 01; 23(4):702-3. PubMed ID: 12692010
    [No Abstract] [Full Text] [Related]

  • 6. Gemfibrozil in hyperlipidaemia: an open, single blind trial.
    Varthakavi PK, Turakhia DP, Sharma SS, Salgaonkar DS, Nihalani KD, Joshi VR.
    J Assoc Physicians India; 1990 Feb 01; 38(2):136-40. PubMed ID: 2380132
    [Abstract] [Full Text] [Related]

  • 7. The effects of gemfibrozil upon the hypercoagulable state in dyslipidaemic patients with chronic renal failure.
    Irish AB, Thompson CH.
    Nephrol Dial Transplant; 1996 Nov 01; 11(11):2223-8. PubMed ID: 8941582
    [Abstract] [Full Text] [Related]

  • 8. Gemfibrozil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in dyslipidaemia.
    Todd PA, Ward A.
    Drugs; 1988 Sep 01; 36(3):314-39. PubMed ID: 3056692
    [Abstract] [Full Text] [Related]

  • 9. Ciprofibrate versus gemfibrozil in the treatment of mixed hyperlipidemias: an open-label, multicenter study.
    Aguilar-Salinas CA, Fanghänel-Salmón G, Meza E, Montes J, Gulías-Herrero A, Sánchez L, Monterrubio-Flores EA, González-Valdez H, Gómez Pérez FJ.
    Metabolism; 2001 Jun 01; 50(6):729-33. PubMed ID: 11398153
    [Abstract] [Full Text] [Related]

  • 10. [Gemfibrozil in the treatment of hyperlipidemia].
    Wang JJ, Song YM, Wang YS, Lin WH.
    Zhonghua Yi Xue Za Zhi (Taipei); 1989 Feb 01; 43(2):131-4. PubMed ID: 2766068
    [Abstract] [Full Text] [Related]

  • 11. Effect of a six month gemfibrozil treatment and dietary recommendations on the metabolic risk profile of visceral obese men.
    Dumont M, Mauriège P, Bergeron J, Després JP, Prud'homme D.
    Int J Obes Relat Metab Disord; 2001 Aug 01; 25(8):1136-43. PubMed ID: 11477498
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of etofibrate and gemfibrozil in combined hyperlipidaemia.
    Wolf HR.
    Drugs Exp Clin Res; 1994 Aug 01; 20(3):109-13. PubMed ID: 7956717
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Hyperlipidemia after renal transplantation: treatment with gemfibrozil.
    Chan TM, Cheng IK, Tam SC.
    Nephron; 1994 Aug 01; 67(3):317-21. PubMed ID: 7936022
    [Abstract] [Full Text] [Related]

  • 16. Apparent reduced absorption of gemfibrozil when given with colestipol.
    Forland SC, Feng Y, Cutler RE.
    J Clin Pharmacol; 1990 Jan 01; 30(1):29-32. PubMed ID: 2303577
    [Abstract] [Full Text] [Related]

  • 17. Effects of gemfibrozil on very-low-density lipoprotein composition and low-density lipoprotein size in patients with hypertriglyceridemia or combined hyperlipidemia.
    Yang CY, Gu ZW, Xie YH, Valentinova NV, Yang M, Yeshurun D, Quion JA, Gotto AM.
    Atherosclerosis; 1996 Sep 27; 126(1):105-16. PubMed ID: 8879439
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.